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CoA is the major acyl carrier in mammals and a key cofactor in
energy metabolism. Dynamic regulation of CoA in different tissues and organs supports metabolic flexibility. Two mammalian
Nudix hydrolases, Nudt19 and Nudt7, degrade CoA in vitro.
Nudt19 and Nudt7 possess conserved Nudix and CoA signature
sequences and specifically hydrolyze the diphosphate bond of
free CoA and acyl-CoAs to form 3ⴕ,5ⴕ-ADP and 4ⴕ-(acyl)phosphopantetheine. Limited information is available on these
enzymes, but the relatively high abundance of Nudt19 and
Nudt7 mRNA in the kidney and liver, respectively, suggests that
they play specific roles in the regulation of CoA levels in these
organs. Here, we analyzed Nudt19ⴚ/ⴚ mice and found that deletion of Nudt19 elevates kidney CoA levels in mice fed ad libitum,
indicating that Nudt19 contributes to the regulation of CoA in
vivo. Unlike what was observed for the regulation of Nudt7 in
the liver, Nudt19 transcript and protein levels in the kidney did
not differ between fed and fasted states. Instead, we identified
chenodeoxycholic acid as a specific Nudt19 inhibitor that competed with CoA for Nudt19 binding but did not bind to Nudt7.
Exchange of the Nudix and CoA signature motifs between the
two isoforms dramatically decreased their kcat. Furthermore,
substitutions of conserved residues within these motifs identified amino acids playing different roles in CoA binding and
hydrolysis in Nudt19 and Nudt7. Our results reveal that the
kidney and liver each possesses a distinct peroxisomal CoA
diphosphohydrolase.
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CoA is an obligate cofactor utilized as an acyl carrier in hundreds of metabolic reactions. Numerous CoA thioesters are
also involved in the post-translational modification of histones
and thousands of other proteins (1–5). Three major subcellular
CoA pools are found in the cytosol, mitochondria, and peroxisomes to support specific metabolic pathways (6, 7). These
include, among others, fatty acid synthesis in the cytosol, the
TCA cycle and oxidation of long-chain and medium-chain fatty
acids in the mitochondria, and bile acid conjugation and
oxidation of very long-chain and branched-chain fatty acids
in the peroxisomes. A dedicated pool of acetyl-CoA is also
found in the endoplasmic reticulum, where it is involved in
protein quality control and autophagy (8), whereas nuclear
acyl-CoAs, which freely equilibrate with the cytosolic pool
across the nuclear pores, contribute to the regulation of gene
expression (5).
Tight control over the concentration of CoA in different
organs is essential to maintain normal metabolism and organ
function. Indeed, elevated CoA levels in the liver of diabetic
mice promote excessive gluconeogenesis and hyperglycemia
(9), whereas a supraphysiological concentration of CoA in skeletal muscle leads to decreased ATP levels and exercise performance (10). Adverse consequences are also associated with
lower-than-normal CoA levels. Decreased synthesis of this
cofactor in the nervous system is associated with a rare neurological disorder in humans (11, 12), whereas decreased synthesis of CoA in the liver leads to fasting hypoglycemia and hepatic
triglyceride accumulation (13). Dynamic regulation of CoA
within the normal physiological range is important to support
the metabolic reprogramming that underlies the capacity to
respond to changes in the metabolic state. For example, the
increase in CoA that characterizes the fed-to-fasted transition
in the liver is driven by the activation of the biosynthetic pathway and is required to sustain the high rates of hepatic fatty acid
oxidation and gluconeogenesis under fasting conditions (13,
14). On the other hand, the net decrease in the concentration of
CoA observed upon refeeding after a fast requires both inhibition of de novo CoA synthesis and active degradation of the
cofactor accumulated in the fasted state.
The existence of a CoA-degradation pathway in the liver and
kidneys is supported by the fact that mice treated with an inhibitor of the CoA biosynthetic pathway exhibit a dramatic reduc-
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tion in hepatic and renal CoA, indicating rapid CoA turnover in
these tissues (15). Liver and kidneys contain high transcript
levels of two Nudix hydrolases, Nudt7 and Nudt19, respectively, which exhibit CoA diphosphohydrolase activity in vitro
(16, 17). Nudix hydrolases hydrolyze the diphosphate bond of a
variety of substrates consisting of a nucleoside diphosphate
linked to another moiety, x (18, 19). All members of the
Nudix superfamily contain the conserved Nudix box motif
G1N[5X]E7N[7X]R15NE16NXXE19NE20NXG22NU (where U is a
hydrophobic residue, X is any residue, and superscript N
denotes the position of a residue of the signature motif within a
specific protein sequence) (20, 21). Additionally, Nudix hydrolases that specifically hydrolyze CoA also contain a putative
CoA binding motif, (L/M)(L/F)TXR(S/A)[3X](R/K)[3X]G[3X]
FPGG (PROSITE accession number PS01293, formerly
UPF0035), upstream of the Nudix box motif (22). The crystal
structure of human NUDT7 has recently been released (PDB3
code 5T3P). Similar to the structure of the bacterial homolog
from Deinococcus radiodurans (24), the crystal structure of the
human enzyme does not contain CoA bound. Thus, the contribution of the CoA motif to CoA binding and the organization of
the CoA-binding site in these enzymes are currently unknown.
Independent studies and approaches have demonstrated
the localization of Nudt7 in the peroxisomes (17, 25). Nudt7
mRNA and protein levels in the liver are regulated by the nutritional state and are inversely correlated with the tissue concentration of CoA (9, 26). Additionally, overexpression of a catalytically active, cytosolic form of Nudt7 has also recently been
shown to cause a decrease in CoA levels in vivo (25).
Significantly less is known about Nudt19. Nudt19 exhibits
modest sequence similarity to Nudt7 (⬃30%), is larger than a
typical Nudix hydrolase, including Nudt7, and contains a
unique 45– 49-amino acid insertion of unknown function
within its Nudix box (16). This enzyme, also known as RP2p,
was originally reported to be a kidney protein whose transcript
levels were robustly up-regulated by androgens (27). Later,
recombinant Nudt19 was shown to specifically hydrolyze CoA
species (16), although modest activity against capped RNA has
also been detected (28). Based on proteomics studies, Nudt19
localization has been reported in both peroxisomes and mitochondria (16, 29); however, it is currently unclear whether the
enzyme has dual localization or exclusively resides in one of the
two subcellular compartments, and which one. Given the presence of dedicated CoA pools and complementary metabolic
processes in peroxisomes and mitochondria, this distinction is
important to gain insight into the physiological role of Nudt19,
even in relation to the other mammalian isoform, Nudt7.
Indeed, it is presently unclear whether Nudt7 and Nudt19,
which seem to be differentially expressed in liver and kidneys,
differ in key aspects of their function.
We have investigated the effect of Nudt19 deletion on CoA
levels, the localization of this enzyme in intact cells, and its
regulation by selected metabolites. Additionally, we used a
3

The abbreviations used are: PDB, Protein Data Bank; CDCA, chenodeoxycholic acid; mBB, monobromobimane; PTS1, peroxisome targeting signal
type 1; ITC, isothermal titration calorimetry; KOMP, Knock-out Mouse
Project.

combination of computational modeling, substrate docking,
and site-directed mutagenesis to identify residues involved in
CoA binding and hydrolysis in Nudt19 and analyzed the role of
equivalent residues in Nudt7. We show that Nudt19 is a peroxisomal enzyme that contributes to the regulation of kidney CoA
levels in vivo and provide evidence supporting the conclusion
that the CoA-binding sites of Nudt19 and Nudt7 are different.

Results
Nudt19 regulates kidney CoA levels in vivo
Previous work has shown that Nudt19 hydrolyzes free CoA
and acyl-CoAs to 3⬘,5⬘-ADP and 4⬘-(acyl)phosphopantetheine
in vitro (16). We confirmed these findings by measuring the
activity of recombinant Nudt19 against several acyl-CoAs and
comparing it to the better characterized Nudt7 (17, 25) (Fig. 1,
A and B). We determined that the optimal concentration of
MgCl2 for Nudt7 and Nudt19 was 4 and 10 mM, respectively,
when free CoA was used as the substrate (data not shown).
However, in experiments where we tested multiple acyl-CoAs,
it was necessary to keep the concentration of MgCl2 at 4 mM for
both Nudt7 and Nudt19 to prevent the precipitation of lauroyland stearoyl-CoA. Under these conditions, the specific activity
per pmol of Nudt19 was lower than that of Nudt7, but the
enzyme readily hydrolyzed short and medium chain acyl-CoAs,
malonyl- and succinyl-CoA, in addition to free CoA (Fig. 1A).
Exceptions were acetyl-CoA and the synthetic monobromobimane (mBB)-CoA, which were excellent substrates for Nudt7,
but not for Nudt19. Nudt19 also had no detectable hydrolytic
activity against ATP, ADP, NAD⫹ NADH, NADP⫹, and
NADPH (data not shown), confirming the specificity of this
enzyme for CoA (16).
The mRNA levels of Nudt19 are highly abundant in mouse
kidneys (16, 30). To examine the distribution of this protein in
mouse tissues, we generated a polyclonal antibody against the
full-length mouse Nudt19. Consistent with the mRNA expression pattern, Nudt19 protein showed the highest abundance in
the kidneys, with lower but still detectable levels in skeletal
muscle and brain (Fig. 1C). This expression pattern was strikingly different from Nudt7, which was expressed at the highest
levels in the liver and, to a significantly lower extent, in white
and brown adipose tissue (Fig. 1C). The high expression level of
Nudt19, combined with the minimally detectable Nudt7 protein in the kidneys (Fig. 1C), suggested that Nudt19 was the
major of the two isoforms in these organs.
To determine whether Nudt19 regulated CoA levels in vivo,
we obtained Nudt19⫹/⫺ mice from the KOMP repository and
bred them to generate Nudt19⫺/⫺ mice and wildtype littermate
controls. The Nudt19⫺/⫺ mice were viable, fertile, and outwardly normal. Successful deletion of the gene was verified by
PCR analysis of tail biopsies (Fig. 2A), whereas Western blotting
analysis confirmed the lack of Nudt19 protein expression (Fig.
2B). Additionally, enzymatic assays confirmed the lack of any
residual formation of 3⬘,5⬘-ADP in kidney homogenates
obtained from Nudt19⫺/⫺ mice (Fig. 2C). The concentration of
CoA was measured in the kidneys of Nudt19⫺/⫺ and control
mice in the fed state and following an overnight fast. In the fed
state, the kidneys of the Nudt19⫺/⫺ mice exhibited a significant
J. Biol. Chem. (2018) 293(11) 4134 –4148
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major CoA diphosphohydrolase in the kidneys and that this
enzyme contributed to the regulation of kidney CoA levels in
vivo.
Mouse Nudt7 and other CoA diphosphohydrolases from
Saccharomyces cerevisiae and Caenorhabditis elegans localize
to the peroxisomes (17, 22, 31), which suggests that these
enzymes might specifically regulate the peroxisomal pool of
CoA (32, 33). Nudt19 contains a C-terminal peroxisome targeting signal type 1 (PTS1), Ala-His-Leu, and was originally identified as a peroxisomal enzyme by the proteomic analysis of
kidney peroxisomes (16). Recently, proteomic studies conducted on isolated mitochondria have also led to the annotation
of Nudt19 as a mitochondrial enzyme in the Mitocarta2.0
inventory (29). Given the common contamination of isolated
peroxisomes and mitochondria with variable amounts of other
organelles, we used immunofluorescence and confocal microscopy to determine the intracellular localization of Nudt19 in
whole HEK 293 cells (Fig. 3). HEK 293 cells were transiently
transfected with constructs expressing Nudt19 with N- or
C-terminal GFP tags. Nuclei were stained with DAPI, mitochondria were stained with MitoTracker威 Orange CMTMRos,
and peroxisomes were visualized with an antibody against the
endogenous peroxisomal protein PMP70. When expressed
with an N-terminal GFP tag that left the PTS1 exposed, Nudt19
colocalized with PMP70, as shown by the yellow pixels resulting
from the overlap of the green and red contributions (Fig. 3,
A–C). Masking the PTS1 of Nudt19 with a C-terminal GFP tag
prevented the peroxisomal localization (Fig. 3, G–I) but did not
direct the protein to the mitochondria (Fig. 3, J–L), leading
instead to a diffuse cytoplasmic localization. Overall, these
results supported the conclusion that Nudt19 was a peroxisomal enzyme. As such, the 20% increase measured in the
whole kidney homogenates from fed Nudt19⫺/⫺ mice (Fig. 2D)
could be an underestimation of the local accumulation of CoA
in the kidney peroxisomes of these animals.
Nudt19, but not Nudt7, is competitively inhibited by specific
bile acids
Figure 1. In vitro activity and tissue distribution of Nudt19 and Nudt7. A
and B, recombinant mouse Nudt19 (A) and Nudt7 (B) were incubated with 250
M of each CoA substrate, and the 3⬘,5⬘-ADP produced was quantified as
described under “Experimental procedures.” The data are plotted as the
mean (bars) of duplicate measurements from two or three independent
experiments (circles) ⫾ S.D. C, immunoblot analysis to detect Nudt19 and
Nudt7 proteins in mouse tissues. Tissue lysate proteins (150 g) were fractionated by SDS-PAGE, transferred to a PVDF membrane, and blotted with the
Nudt19 antibody. The same membrane was then stripped and blotted with
antibodies against GAPDH (loading control) and Nudt7. Note that although
the same amount of protein was loaded, different tissues contain different
amounts of GAPDH. Panc., pancreas; WAT, white adipose tissue; BAT, brown
adipose tissue; NS, nonspecific band.

20% increase in the concentration of CoA compared with the
wildtype mice (Fig. 2D). Fasting induced an increase in kidney
CoA levels in both wildtype and Nudt19⫺/⫺ mice. Under these
conditions, the concentration of CoA in the Nudt19⫺/⫺ kidneys tended to be higher than control mice, but the difference did not reach statistical significance. No compensatory
increase in Nudt7 transcript levels was detected in the kidneys of the Nudt19⫺/⫺ mice in either the fed or fasted states
(Fig. 2E). Combined, these data showed that Nudt19 was the
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Deletion of Nudt19 led to a significant increase in kidney
CoA levels in fed but not fasted mice (Fig. 2D). This suggested
that, in a wildtype mouse, the activity of Nudt19 might be
higher in the fed state compared with the fasted state. We analyzed Nudt19 mRNA and protein expression levels in the kidneys of mice fed ad libitum and mice fasted for up to 48 h, but
we did not detect any difference (Fig. 4, A–C). We then focused
our attention on metabolite regulation.
We screened a panel of 30 compounds, including a large
number of substrates and products of peroxisomal metabolism,
for their effect on the activity of recombinant Nudt19 (Table 1).
None of the compounds tested significantly stimulated Nudt19
activity. Instead, we found that a select group of bile acids inhibited the enzyme by ⬎50%. More specifically, chenodeoxycholic
acid (CDCA) and its conjugated derivatives, taurochenodeoxycholic acid and glycochenodeoxycholic acid, decreased Nudt19
activity by 60 –75% with respect to vehicle control (Table 1).
More hydrophobic bile acids, such as lithocholic acid and ursocholanic acid, were also potent inhibitors of Nudt19, and
␣-muricholic acid, which derives from CDCA by the addition of

Differential regulation of Nudt19 and Nudt7

Figure 2. Effect of Nudt19 deletion on kidney CoA levels. A, mouse genotyping. Multiplex PCRs were set up to detect the wildtype and/or the knockout
allele, as described under “Experimental procedures.” A PCR product of 185 bp indicated a wildtype allele; a PCR product of 466 bp indicated a knockout allele.
Heterozygous mice exhibited both bands. M, marker; WT, wildtype; Hz, heterozygous; KO, knockout. B, Western blotting analysis of kidney homogenates (150
g) from wildtype and Nudt19⫺/⫺ mice using the Nudt19 antibody. GAPDH was used as a loading control. NS, nonspecific band. C, production of 3⬘,5⬘-ADP in
reaction mixtures containing free CoA and kidney extracts from wildtype and Nudt19⫺/⫺ mice. Numbers in parentheses represent the number of animals
analyzed; data are reported as the means ⫾ S.D. D, total CoA measured in the kidneys of wildtype and Nudt19⫺/⫺ mice fed ad libitum or fasted overnight (ON).
E, Nudt7 mRNA abundance in the kidneys of fed and fasted wildtype and Nudt19⫺/⫺ mice. D and E, data are reported as the mean (bars) of measurements on
individual mice (circles and squares) ⫾ S.D. **, p ⬍ 0.01 relative to wildtype mice; #, p ⬍ 0.05; ##, p ⬍ 0.01; ###, p ⬍ 0.001 relative to the fed state.

a 6␤-hydroxyl group, still retained significant potency against
the enzyme. In contrast, cholic acid and its glycine and taurine
conjugates exhibited decreased potency against Nudt19 compared with CDCA. Furthermore, other steroid compounds,
such as progesterone, pregnenolone, and corticosterone, had
no significant effect on the activity of the enzyme, confirming
the specificity of the inhibitory effect of CDCA and derived bile
acids on Nudt19 (Table 1).
Interestingly, none of the compounds tested, including
CDCA, significantly affected the activity of Nudt7 (Table 1). In
addition, isothermal titration calorimetry (ITC) studies showed
no detectable binding of CDCA to the liver enzyme, whereas
the Kd of the Nudt19-CDCA complex was determined to be 8.3
M (⌬G ⫽ ⫺6.9 kcal/mol) (Fig. 5, A and B). Further kinetic
analysis of the mechanism of Nudt19 inhibition revealed that
CDCA was a competitive inhibitor with respect to free CoA
(Fig. 5C). Combined, these results identified CDCA as a specific
competitive inhibitor of Nudt19 in vitro.
The CoA boxes and the Nudix signature sequences of Nudt19
and Nudt7 are not interchangeable
Bile acids are primarily synthesized and conjugated in the
liver. Although the potential relevance of Nudt19 inhibition by

a select group of these compounds in vivo is currently not
known, the lack of CDCA binding to Nudt7 and the competitive
nature of the CDCA inhibition of Nudt19 strongly suggested
that the CoA-binding sites of the two enzymes might be different. Nudix hydrolases that degrade CoA contain a conserved
motif, (L/M)(L/F)TXR(S/A)[3X](R/K)[3X]G[3X]FPGG, here
referred to as the CoA box, which is proposed to play a role in
CoA binding (24) (Fig. 6A). Based on the structures of both
human NUDT7 and the D. radiodurans homolog, the CoA box
comprises the three ␤ strands ␤2, ␤3, and ␤4, whereas the
Nudix signature sequence, G1N[5X]E7N[7X]R15NE16NXXE19
N
E20NXG22NU, here referred to as the Nudix box, forms a
␤-strand-loop/helix/loop structural motif (Fig. 6A) (21, 34, 35). In
several validated CoA diphosphohydrolases, the Nudix box
exhibits a variable number of X residues between E7N and R15N.
The most extreme case is represented by mouse and human
Nudt19, which contain a 45– 49-amino acid insertion (Fig. 6A).
Given its position within the Nudix box, this insertion would
occur between strand ␤4 and helix ␣2, i.e. in the first loop of the
Nudix ␤-strand-loop/helix/loop structural motif (Fig. 6A).
We swapped the CoA box in Nudt7 and Nudt19, generating
a chimeric Nudt7 with the Nudt19 CoA box, Nudt7-19-CB, and
J. Biol. Chem. (2018) 293(11) 4134 –4148
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Figure 3. Localization of Nudt19 to the peroxisomes. HEK 293 cells were transfected with expression plasmids encoding for GFP fused to the N terminus
(Nudt19-N-GFP) (A–F) or the C terminus of Nudt19 (Nudt19-C-GFP) (G–L). Fixed cells were visualized using confocal microscopy. B, C, H, and I, the endogenous
PMP70 protein was used as a marker for the peroxisomes, shown in red. E, F, K, and L, mitochondria were visualized using MitoTracker Orange CMTMRos and
shown in red. A–L, cell nuclei were stained with DAPI, in blue. C, F, I, and L, insets in merged images show details at higher magnification. The results are
representative of at least two independent experiments.

a chimeric Nudt19 with the Nudt7 CoA box, Nudt19-7-CB. We
also substituted the Nudix box of Nudt7 with that of Nudt19
producing a Nudt7-19-NB chimera. All three chimeras were
expressed and purified in amounts similar or higher compared
with the wildtype Nudt7 and Nudt19. Conversely, exchanging
the Nudix box in Nudt19 with the shorter Nudt7 Nudix box
produced a protein that could be expressed but not purified as a
soluble enzyme. Interestingly, a similar result was obtained
when we expressed a Nudt19(⌬58 –103) mutant lacking the
unique insertion sequence in the Nudix box (data not shown),
suggesting that this amino acid stretch could be important for
the folding and/or stability of Nudt19. The three soluble chimeras were analyzed by analytical gel filtration to assess their folding. Based on their calculated molecular weight, ⬃70% of
Nudt19-7-CB, Nudt7-19-CB, and Nudt7-19-NB eluted as glob-
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ular monomers, similar to wildtype Nudt7 and Nudt19 (Fig.
6B). Smaller peaks, indicating the formation of multimers, were
also detected in both the chimeras and the wildtype enzymes
(Fig. 6B). Despite evidence of protein folding, the specific activities of Nudt19-7-CB, Nudt7-19-CB, and Nudt7-19-NB were
decreased 2–3 orders of magnitude compared with the respective wildtype enzymes (Fig. 6C). In particular, the substitution
of the CoA box of Nudt19 with that of Nudt7 caused ⬎5,000fold decrease in the kcat and a 3-fold increase in the Km for free
CoA compared with Nudt19 (Table 2). Similarly, swapping the
Nudt7 CoA box with the CoA box of Nudt19 in Nudt7-19-CB
led to a 500-fold decrease in kcat and a 5-fold increase in Km.
Finally, exchanging the Nudix box in Nudt7-19-NB caused a
200-fold decrease in kcat and a 3-fold increase in Km compared
with Nudt7 (Table 2).

Differential regulation of Nudt19 and Nudt7
Table 1
Effect of selected metabolites on the activity of Nudt19 and Nudt7
Nudt19 and Nudt7 were assayed in the presence of 250 M of each compound,
unless otherwise indicated, and free CoA as substrate. A minus sign indicates a
decrease in activity with respect to the vehicle control. A plus sign indicates an
increase in activity with respect to the vehicle control. NMN, nicotinamide mononucleotide.
Activity relative to vehicle
Metabolite

Nudt19

Hydrogen peroxide (10 M)
Hydrogen peroxide (100 M)
ATP
NAD⫹
NADH
NADP⫹
NADPH
NMN
Pyruvate
␣-Ketoglutarate
Isocitrate
Sarcosine
Carnitine
Glycine
Taurine
Lauric acid
Palmitic acid (50 M)
Palmitoylcarnitine (50 M)
Cholic acid
Glycocholic acid
Taurocholic acid
Chenodeoxycholic acid
Glycochenodeoxycholic acid
Taurochenodeoxycholic acid
␣-Muricholic acid
Lithocholic acid (50 M)
Ursocholanic acid (50 M)
Corticosterone
Progesterone
Pregnenolone
a

⫹16
⫹3
⫹6
⫺5
⫺13
⫺16
⫺5
⫺8
⫹13
0
⫺9
⫹8
⫺3
⫺4
⫹5
⫺16
⫺2
⫹23
⫺24
⫺30
⫺17
⫺62a
⫺67a
⫺75a
⫺50a
⫺83a
⫺70a
⫺26
⫺37
⫺15

Nudt7
%

⫺11
⫹5
⫹2
⫹1
⫹20
⫹4
⫹7
⫺1
⫺17
⫺8
⫺5
⫹4
⫺1
⫹16
⫹24
⫺4
⫺32
⫹11
⫹8
⫹10
⫹3
⫹1
⫹3
⫹11
⫺8
⫺15
⫹12
⫺7
0
⫹14

Metabolites that decreased or increased the activity ⱖ50%.

with the dramatic reduction in kcat and robust decrease in Km
(Table 2), the altered substrate specificity of the chimeras suggested that swapping the Nudix and CoA boxes between
Nudt19 and Nudt7 might have caused a substantial deformation of the respective active sites.
Mutagenesis-guided modeling of Nudt19
Figure 4. Nudt19 expression in the kidneys of fed and fasted mice. A,
Nudt19 transcript levels in the kidneys of fed, overnight (ON) fasted, and 48 h
fasted mice. B, Western blotting analysis showing that Nudt19 protein levels
in the kidneys did not change between fed, overnight fasted, and 48 h fasted
mice. ␣-Tubulin was used as a loading control. C, quantification of the Western blot in B. The data are reported as the mean (bars) of measurements on
individual mice (circles, squares, and diamonds) ⫾ S.D.

Wildtype Nudt19 and Nudt7 readily degrade free CoA and
lauroyl-CoA but exhibit different activities against acetyl-CoA
and mBB-CoA, which are good substrates for Nudt7 but not
Nudt19 (Fig. 1, A and B). We next determined the effect of
swapping the Nudix and CoA boxes on the substrate specificity
of the three soluble chimeras Nudt19-7-CB, Nudt7-19-CB, and
Nudt7-19-NB (Fig. 6D). For each enzyme, the activity data with
the different substrates were plotted relative to free CoA to
allow for comparison across enzymes with dramatically different specific activities. All three proteins, including the Nudt19
chimera Nudt19-7-CB, degraded acetyl-CoA and mBB-CoA,
with a significantly higher relative preference for the latter substrate compared with wildtype Nudt7 and Nudt19. Combined

The recently released crystal structure of human NUDT7 is
the only currently available structure of a mammalian CoA
diphosphohydrolase. This structure does not contain any divalent cation, essential to correctly orient the diphosphate bond
of the substrate for hydrolysis, or CoA bound (PDB code 5T3P).
To identify Nudt19 residues involved in CoA and possibly
CDCA binding, we decided to build a model of the putative
structure of Nudt19 in complex with Mg2⫹ and free CoA using
a computational approach guided by mutational analysis.
Within the Nudix box, the carbonyl group of G1N and two of
the three glutamates in the E16N, E19N, and E20N series, participate in the coordination of the essential divalent cation (24,
34 –39). E16N, E19N, and E20N correspond to Glu-112, Glu-115,
and Glu-116 in Nudt19, respectively (Figs. 6A and 7C). Mutation of these residues to alanine abolished the enzymatic activity of Nudt19 E112A and Nudt19 E116A (Table 2). The activity
of Nudt19 E115A was detectable; however, the enzyme exhibited a ⬃2000-fold decrease in kcat and a 3-fold increase in Km
(Table 2). Interestingly, the effect of this mutation on the Km
suggested that this residue of the Nudix box contributed to CoA
J. Biol. Chem. (2018) 293(11) 4134 –4148
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Figure 5. CDCA binds to Nudt19 but not to Nudt7. A and B, ITC binding curves of Nudt19 (A) and Nudt7 (B). The binding curves are representative of two or
three independent experiments. C, graphical analysis of CDCA inhibition of Nudt19 using fixed concentrations of the inhibitor and variable concentrations of
free CoA revealed that CDCA was competitive with free CoA. The data are reported as the mean of two independent experiments in duplicate ⫾ S.D.

binding. We also mutated the equivalent Nudt7 residues E1692,
E1995, and E2096. Similar to the Nudt19 mutants, Nudt7 E92A
and Nudt7 E96A did not show any detectable activity. Mutation
of Nudt7 Glu-95 to alanine decreased the kcat ⬎10-fold, but
unlike the equivalent mutant in Nudt19, it had no significant
effect on the Km for CoA. Overall, these results were consistent
with mutagenesis studies conducted on other Nudix hydrolases
(36, 40, 41) and confirmed the importance of E16N, E19N, and
E20N for the activity of both Nudt19 and Nudt7. The crystal
structure of the CoA diphosphohydrolase from D. radiodurans,
CoAse, contains Mg2⫹ bound (24). Although unable to fit completely, docking of free CoA onto the “closed” structure of the
bacterial CoAse suggested the existence of a potential contact
between the side chain of Arg-55, the first arginine in the CoA
box (Fig. 6A), and the diphosphate bond of CoA (24). Additionally, mutation of the equivalent residue to a glutamine in the
Arabidopsis thaliana homolog AtCoAse led to a dramatic
decrease in activity (42). This arginine residue is highly conserved across CoA diphosphohydrolases, and corresponds to
Arg-34 in Nudt19 and Arg-60 in Nudt7 (Fig. 6A). Mutation of
these residues to a methionine, an amino acid with a comparable side chain but no charge, dramatically decreased the kcat of
the Nudt19 R34M and Nudt7 R60M mutants by 2000- and 200fold, respectively, and caused a 2–3-fold increase in the Km.
Combined, these data supported the importance of this residue
for catalysis.
We used this information as a guide to evaluate computational models of Nudt19 generated by using the YASARA modeling software suite (43). Specifically, the final model that we
selected exhibited 1) the correct positioning of E16112, E19115,
and E20116 with respect to Mg2⫹, 2) the appropriate orientation
of the diphosphate moiety of free CoA with respect to Mg2⫹ to
allow for catalysis, and 3) interaction of Arg-34 with the diphosphate group of the substrate CoA (Fig. 7, B and C). In this
model, the CoA and Nudix boxes of Nudt19 folded into the
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expected structural motifs with very good superposition
with the CoA and Nudix boxes of the D. radiodurans CoAse
and human NUDT7 (Fig. 7A). Within the ␤-strand-loop/
helix/loop structural motif of the Nudix box, the 45-amino
acid insertion in Nudt19 was modeled as an expansion in the
loop connecting the strand ␤4 to the helix ␣2 and was mostly
unstructured.
Identification of additional residues involved in CoA binding
and hydrolysis
Based on the model, we selected and mutated a set of Nudt19
residues predicted to participate in the binding of CoA (Table
2). In particular, we mutated Arg-39, Phe-40, Leu-41, which are
part of the CoA box, and Arg-189 to alanine (Figs. 6A and 7C).
In the Nudt19 model, the side chains of Phe-40 and Leu-41
extended toward the free thiol end of the CoA molecule,
whereas the side chain of Arg-39 extended toward the 3⬘-phosphate of the CoA adenine ring (Fig. 7C). Mutation of Phe-40
and Leu-41 to alanine caused a robust 3– 4-fold increase in the
Km, confirming that these residues played a role in CoA binding. In addition, the Nudt19 L41A mutant also showed a
⬃3-fold decrease in kcat. Mutation of Arg-39 to an alanine did
not have a significant effect (⬍2-fold) on the Km; however,
removal of the positive charge caused a 3-fold decrease in kcat,
indicating that this residue was nevertheless important for CoA
hydrolysis. Arg-189 was located in a loop region outside the
CoA box and stretched toward the adenosine moiety of CoA
(Fig. 7C). The Nudt19 R189A mutant exhibited a 4-fold
increase in Km and a 2-fold decrease in kcat, confirming that
Arg-189 was important for both CoA binding and hydrolysis.
We further investigated the role of this residue by mutating
Arg-189 to a methionine. Unlike alanine, the side chain of
methionine was able to functionally replace Arg-189, thus suggesting the existence of potential non-polar side chain interaction(s) between Arg-189 and CoA (Table 2). Because Nudt19
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Figure 6. Effect of exchanging the CoA and Nudix boxes of Nudt19 and Nudt7. A, alignment of the CoA and Nudix boxes of characterized CoA diphosphohydrolases from different organisms. Invariant residues are highlighted in red, conserved residues are highlighted in yellow, and groups of conserved
residues are boxed. The Nudix and the CoA boxes overlap at a glycine highlighted in black. Residues mutated in both Nudt19 and Nudt7 are marked with blue
stars. Residues mutated just in Nudt19 are marked with a blue open circle. Secondary structure elements of the D. radiodurans CoAse (Dr1184; PDB code 1NQZ)
and human NUDT7 (HsNUDT7; PDB code 5T3P) are shown on top of the alignment. The unique insertion sequence found in mouse and human Nudt19 would
be inserted (blue inverted triangle) in the loop region between the ␤ strand and the ␣ helix of the Nudix box structural motif. Mm, Mus musculus; Hs, Homo
sapiens; Dr, D. radiodurans; Sc, S. cerevisiae; Ce, C. elegans. GenBankTM accession numbers for the aligned proteins are as follows: MmNudt7,165972342;
HsNUDT77, 157785656; MmNudt19, 187954021; HsNUDT19, 157739940; Dr1184, 6458920; ScPcd1p, 6323180; and CeNdx8, 68565843. B, calibration curve of
the Superdex 75 10/300 GL column and elution profile of wildtype Nudt19, Nudt7, and chimeras. The native molecular weights of the protein peaks, as
estimated from the calibration curve, are reported for each enzyme. The calculated molecular weights of the recombinant His-tagged proteins, based on the
amino acid composition, are: wildtype Nudt19, 42.6 kDa; Nudt19-7-CB, 42.6 kDa; wildtype Nudt7, 29.2 kDa; Nudt7-19-NB, 34.0 kDa; and Nudt7-19-CB, 29.1 kDa.
C, specific activity of the recombinant Nudt19, Nudt7, and chimeric proteins. Specific activities ⫾ standard error were calculated from the linear regression of
five-point protein curves obtained for each enzyme from at least two independent experiments in duplicate. D, substrate specificity of Nudt19, Nudt7, and
chimeric proteins. Activity with each CoA species is expressed as percentage relative to the activity with free CoA. The data are reported as the mean (bars) of
duplicate measurements from two or three independent experiments (circles) ⫾ S.D.

R34M, F40A, L41A, and R189A mutants exhibited a reduced
affinity for CoA (Table 2), we tested the sensitivity of these
mutants to inhibition by the competitive inhibitor CDCA (Fig.

5C). At a concentration of 250 M of free CoA, the IC50 of
CDCA was determined to be 125 M against wildtype Nudt19.
Among the above mutants, Nudt19 R34M retained ⬃80% of
J. Biol. Chem. (2018) 293(11) 4134 –4148
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Table 2
Kinetic parameters of Nudt19 and Nudt7 mutants and chimeras
The experiments were conducted in duplicate as described under “Experimental
procedures.” Kinetic constants were determined by nonlinear regression analysis of
the data and expressed ⫾ S.E.
Mutation

a

Km

kcat

M

1/min

Nudt19
WT
Nudt19-7-CB
E112A
E115A
E116A
R34M
R39A
F40A
L41A
D53A
R189A
R189M

300 ⫾ 40
1134 ⫾ 284
N.D.a
1019 ⫾ 226
N.D.
680 ⫾ 186
511 ⫾ 64
1053 ⫾ 153
1250 ⫾ 125
434 ⫾ 59
1193 ⫾ 184
455 ⫾ 80

284 ⫾ 12
0.05 ⫾ 0.01
N.D.
0.16 ⫾ 0.02
N.D.
0.12 ⫾ 0.01
91 ⫾ 4
210 ⫾ 12
101 ⫾ 4
323 ⫾ 16
118 ⫾ 11
177 ⫾ 10

Nudt7
WT
Nudt7-19-CB
Nudt7-19-NB
E92A
E95A
E96A
R60M
K65A
R66A
R66M
D79A

283 ⫾ 94
1362 ⫾ 328
836 ⫾ 173
N.D.
444 ⫾ 87
N.D.
1010 ⫾ 155
958 ⫾ 277
3069 ⫾ 407
496 ⫾ 79
334 ⫾ 29

125 ⫾ 12
0.28 ⫾ 0.03
0.65 ⫾ 0.04
N.D.
10 ⫾ 0.7
N.D.
0.55 ⫾ 0.03
463 ⫾ 56
220 ⫾ 10
167 ⫾ 7
159 ⫾ 5

N.D. indicates that the parameters were not determined because of undetectable
enzymatic activity.

activity in the presence of CDCA (Fig. 7D), suggesting that
Arg-34 might be involved in both CoA and CDCA binding.
Although one of the variable X residues in the Nudix box,
Nudt19 Asp-53 is highly conserved among the CoA diphosphohydrolases (Fig. 6A). In the Nudt19 model, this residue showed
no interaction with CoA, but we nevertheless mutated it to
alanine to determine the effect of the mutation on Km and kcat.
Consistent with the model, the Nudt19 D53A mutant exhibited
kinetic parameters similar to the wildtype enzyme, and we
obtained similar results with the equivalent Nudt7 D79A
mutant (Table 2). The sequence alignment of the CoA diphosphohydrolases also showed that it was common to find a positively charged residue in the same position as Nudt19 Arg-39, a
residue involved in catalysis but not CoA binding (Table 2). We
mutated the equivalent residue in Nudt7, Lys-65, to alanine.
The Nudt7 K65A mutant exhibited a ⬃3-fold increase in both
Km and kcat, showing a differential effect on both kinetic parameters with respect to Nudt19. Finally, because Phe-40 in Nudt19
was involved in substrate binding, we mutated the equivalent
Nudt7 Arg-66 to both alanine and methionine. Nudt7 R66A
showed a ⬎10-fold increase in Km, whereas the Nudt7 R66M
mutant exhibited kinetic parameters similar to the wildtype
enzyme (Table 2). These results supported the conclusion that
the side chain of Arg-66 participated in CoA binding through
hydrophobic interactions and suggested that Phe-40 in Nudt19
and Arg-66 in Nudt7 might be functionally similar.

Discussion
To gain insight into the physiological role of Nudt19, a Nudix
enzyme with CoA diphosphohydrolase activity, one the major
goals of this study was to determine the ability of the enzyme to
regulate CoA levels in vivo. The present work demonstrates
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Figure 7. Homology model of Nudt19 with magnesium ion and free CoA
bound. A, alignment of the CoA and Nudix box regions of the Nudt19 model
(cyan) with the crystal structures of human NUDT7 (purple; PDB code 5T3P)
and D. radiodurans CoAse (gray; PDB code 1NQZ). B, the homology model for
Nudt19 with Mg2⫹ bound (orange sphere) was obtained using the YASARA
modeling software suite. Free CoA (sticks) was then docked using MOE, and
the resultant complex was evaluated and selected as described in the text.
Structural elements in the CoA and Nudix boxes are shown in green and cyan,
respectively. The unique amino acid insertion in the Nudix box of Nudt19 is
shown as a red dotted line in both A and B. C, mode of CoA binding to Nudt19,
with potentially interacting residues shown. D, activity of Nudt19 mutants
incubated with or without the competitive inhibitor CDCA. The data are
reported as the mean (bars) of duplicate measurements from two or three
independent experiments (circles) ⫾ S.D.

that Nudt19 degrades CoA and contributes to the regulation of
this cofactor in the kidneys. Indeed, Nudt19⫺/⫺ mice exhibited
a significant 20% increase in total CoA levels in whole kidney
homogenates obtained from fed mice (Fig. 2D). This result is
consistent with the very narrow tissue distribution of the protein, which showed the highest expression levels in the kidneys,
with brain and skeletal muscle containing barely detectable levels of Nudt19 (Fig. 1C).
The second goal of this study was to address conflicting
reports on the peroxisomal and mitochondrial localization of
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Nudt19, because peroxisomes and mitochondria contain separate pools of CoA and are the sites of distinct CoA-dependent
metabolic processes (7, 44). Using immunofluorescence and
constructs expressing Nudt19 with either a C-terminal or an
N-terminal GFP tag, we showed that the enzyme resides in the
peroxisomes and not in the mitochondria (Fig. 3), thus suggesting a specific role for Nudt19 in peroxisomal metabolism. In the
peroxisomes, free CoA and acyl-CoAs are imported through
dedicated transporters (45, 46) and participate in several processes including the ␣- and ␤-oxidation of fatty acids that are
not substrates for the mitochondrial oxidative machinery, the
synthesis of ether phospholipids and, in the liver, the final steps
in bile acid synthesis and conjugation. Additionally, because
imported CoA species and other molecules ⬎400 Da cannot
freely exit the peroxisomes, the Nudix-mediated hydrolysis of
CoA species to 3⬘,5⬘-ADP and 4⬘-(acyl)phosphopantetheine
likely prevents CoA buildup in this organelle (32, 33). Indeed, it
has been proposed that the function of peroxisomal CoA-degrading enzymes, including Nudt7 and now Nudt19, is to regulate the peroxisomal CoA pool and, in turn, peroxisomal lipid
metabolism (32). Consistent with this proposed role, Nudt19
activity was highest with free CoA, which is required in multiple
peroxisomal pathways, and with succinyl-CoA and C8-C12
acyl-CoAs, which are the oxidation products of dicarboxylic
and very long-chain fatty acids, respectively (Fig. 1A). Nudt19
was previously reported to possess mRNA decapping activity in
vitro (28). Although detectable, the hydrolytic activity of
Nudt19 against capped RNA was minimal when compared with
that of established mRNA decapping enzymes such as Dcp2
and Nudt16 (28). Additionally, mRNA decapping occurs in
cytosolic foci (47). Thus, the peroxisomal localization of
Nudt19, combined with its effect on CoA levels in vivo, argues
against a role for this enzyme in mRNA decapping.
The peroxisomal localization of Nudt19 and fact that the
enzyme could affect just one of the subcellular CoA pools could
also explain the relatively small increase in total CoA levels
observed in whole kidney homogenates obtained from
Nudt19⫺/⫺ mice in the fed state. In the fasted state, the concentration of kidney CoA was higher than in the fed state and
similar between wildtype control and Nudt19⫺/⫺ mice. These
results suggest that the increase in kidney CoA levels that
occurs upon fasting may be promoted more by activation of the
CoA biosynthetic pathway than by a decrease in CoA degradation. The flux through the CoA biosynthetic pathway is controlled by the pantothenate kinase (PanK) isoforms, and PanK1,
which is the isoform that drives the increase in CoA levels
observed in the liver of fasted mice, is also the major PanK
isoform in the kidneys (13, 48). Upon refeeding, a net decrease
in CoA levels requires not only inhibition of CoA synthesis, but
also active degradation of the cofactor accumulated in the
fasted state. This might explain why the effect of deleting
Nudt19 on kidney CoA levels was mostly detected in fed mice.
Interestingly, although the Nudt19⫺/⫺ mice exhibited higher
kidney CoA levels in the fed state compared with control mice,
this concentration of the cofactor was still significantly lower
than in the fasted state, suggesting the existence of residual
CoA-degrading activity in the absence of Nudt19. Nudt7 and
Nudt19 are the only currently confirmed CoA-degrading

enzymes, and in the kidneys, Nudt7 is a minor isoform (Fig. 1C,
and compare Fig. 2E to Fig. 4A). Under our experimental conditions, the production of 3⬘,5⬘-ADP in kidney extracts from
Nudt19⫺/⫺ mice was undetectable (Fig. 2C), and we did not
observe any compensatory up-regulation of Nudt7 (Fig. 2E).
Despite this, an accurate estimate of the contribution of Nudt7,
if any, to the regulation of kidney CoA levels, will require the
generation of mice with a deletion in both Nudt7 and Nudt19.
Alternatively, CoA might be hydrolyzed to products other than
3⬘,5⬘-ADP and 4⬘-(acyl)phosphopantetheine by a novel class of
CoA-degrading enzymes that may or may not reside in the
peroxisomes.
The narrow and non-overlapping tissue distribution of
Nudt19 and Nudt7 in kidneys and liver, respectively, is intriguing. Another major goal of this study was to investigate the
distinctive biochemical and regulatory properties of these
enzymes to gain insight into the physiological roles that Nudt19
and Nudt7 may play in their respective organs. Nudt19 (42 kDa)
is significantly larger than Nudt7 (27 kDa) and contains unique
sequence regions, the most notable of which is the 45-amino
acid insertion in the Nudix box, which are not present in Nudt7
(Fig. 6A). Nudt7 expression in the liver decreases in the fasted
state and increases in the fed state, showing an inverse correlated with the hepatic concentration of CoA (9, 26). Conversely,
Nudt19 mRNA and protein levels in the kidneys did not change
between the fed and fasted states, despite the fact that this
enzyme contributes to the regulation of kidney CoA levels.
While searching for potential small molecule regulators, we
identified CDCA as a competitive inhibitor of Nudt19 that did
not bind to Nudt7, strongly suggesting that these two enzymes
possess distinct CoA-binding sites (Fig. 5). Interestingly, binding of CDCA to Nudt19 depended, at least in part, on Arg-34
(Arg-60 in Nudt7), a highly conserved residue involved in CoA
binding and hydrolysis in both Nudt19 and Nudt7 (Figs. 6A and
7D and Table 2). Additional evidence in support of a different
organization of the CoA-binding sites between the two isoforms is provided by the different activities that Nudt19 and
Nudt7 displayed against substrates such as acetyl-CoA and
mBB-CoA and by the dramatic decrease in kcat observed upon
exchange of the CoA and Nudix boxes between the two
enzymes. Furthermore, the invariant E19N in the Nudix box was
found to participate in CoA binding in Nudt19 but not Nudt7,
whereas the conserved (Arg/Lys) residue in the CoA box (corresponding to Lys-65 in Nudt7 and Arg-39 in Nudt19) was
found to be involved in CoA binding in Nudt7 but not Nudt19.
No structural information on CoA diphosphohydrolases
with CoA bound is currently available, and this represents a
limitation to the accurate prediction of the mode of CoA binding through homology models. Despite this, mutational analysis based on the Nudt19 model that we generated allowed us to
identify residues that are important for CoA binding and hydrolysis (Table 2). These residues were found both within and
outside the CoA box. The Nudt19 model also shows that the
45-amino acid insertion within the Nudix box may be mostly
disordered. Within a protein, disordered regions can exert different functions, including providing display sites for posttranslational modification and/or mediating protein–protein
interactions (49). There are only a few known examples of perJ. Biol. Chem. (2018) 293(11) 4134 –4148
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oxisomal proteins regulated through reversible post-translational modifications (50, 51), and the role of this potentially
disordered sequence, if any, in the regulation Nudt19 activity
remains to be elucidated. We also docked Mg2⫹ and free CoA
to the NUDT7 crystal structure to determine whether we could
find a pose that would agree with the mutational analysis on the
closely related mouse Nudt7 and provide us with a model of
CoA binding to NUDT7. As for Nudt19, we selected the most
likely models using the position of E1692, E1995, E2096, Arg-60,
CoA, and Mg2⫹. In these models, Arg-66 (equivalent to Arg-66
in mouse Nudt7) would form a salt bridge with the diphosphate
moiety of CoA (data not shown). Although the 10-fold increase
in Km of the Nudt7 R66A mutant supports the importance of
Arg-66 for substrate binding, the lack of effect of the R66M
mutation on the kinetic parameters of the enzyme indicates
that the requirement for Arg-66 is likely spatial and geometric
and not about the charge (Table 2). Thus, in this case, the docking of CoA to the structure of NUDT7 does not seem to provide
a close representation of how CoA binds to this enzyme. Crystallization of NUDT7 and possibly Nudt19 with a substrate
bound will be required to yield further details of CoA binding.
Finally, bile acids are synthesized de novo exclusively in the
liver, with the last steps in the synthesis and conjugation to
glycine and taurine occurring in the peroxisomes (52).
Although it may be unlikely for Nudt19 to encounter high concentrations of CDCA in kidney peroxisomes, Nudt7 is presumably exposed to high concentrations of CDCA, cholic acid, and
conjugated derivatives in liver peroxisomes. Thus, it is tempting to speculate that the ability of Nudt7 to remain active even
at high micromolar concentrations of bile acids is one possible
reason for the selection of this enzyme as the major CoA
diphosphohydrolase in the liver. As for Nudt19, further studies,
including an in depth characterization of the Nudt19⫺/⫺ mice,
will be required to determine what selective advantage(s) this
isoform may confer to the kidneys.

Experimental procedures
Materials
Reagents were purchased from the following suppliers: oligonucleotides, Lipofectamine 2000, cell culture reagents, Alexa
Fluor 555- and horseradish peroxidase-conjugated goat antirabbit IgG from Thermo Fisher Scientific; restriction enzymes,
DNA polymerases, and the Q5威 site-directed mutagenesis kit
from New England Biolabs; HEK 293 cells from the American
Type Culture Collection; and the GAPDH antibody from Cell
Signaling. The PMP70 antibody was purchased from Sigma–
Aldrich. The antibody against the full-length mouse Nudt19
was raised in rabbit and purified by antigen affinity chromatography. The Nudt7 antibody was generated as previously
described (9). mBB-CoA was synthesized from free CoA and
monobromobimane (Echelon Biosciences) as described by
Shimada and Mitamura (53). The conversion of free CoA to
mBB-CoA was ⬎99.0%, as estimated by HPLC. All other
reagents were of analytical grade or better and were purchased from Sigma–Aldrich or Fisher Scientific, unless otherwise stated.
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Animal studies
Nudt19tm1(KOMP)Vlcg embryos, obtained by replacing the
Nudt19 gene with a ZEN-UB1 cassette harboring the lacZ
reporter and neo resistance gene, were purchased from the
Knock-out Mouse Project (KOMP) repository and implanted
into pseudopregnant foster mothers by the Transgenic Animal
Core Facility at West Virginia University. The progeny was
screened for the deletion of the Nudt19 gene by multiplex PCR
analysis using the Accustart II PCR genotyping kit (QuantaBio)
and the following KOMP primers: Reg-NeoF (GCAGCCTCTGTTCCACATACACTTCA), Reg-Nudt19-R (TTCACAACCTGCCAAAATGGCTACC), Reg-Nudt19-wtF2 (GGAAACGGGAACAGAGAAACAGG), and Reg-Nudt19-wtR (AAGGACTCAACTCTCACCCTAAGCG). The Nudt19 knockout
allele yielded a product of 466 bp. Although smaller than the
size of 584 bp predicted by the KOMP repository, this 466-bp
amplicon contained the expected 3⬘ end of the ZEN-UB1 cassette (124 bases) and a sequence corresponding to the genomic
region downstream of the Nudt19 gene (342 bp), as confirmed
by sequencing. The wildtype allele yielded a product of the
expected size of 185 bp. Homozygous Nudt19⫺/⫺ mice and
wildtype C57BL6/N littermate controls were obtained through
heterozygous ⫻ heterozygous breeding. The mice were fed a
standard chow diet (Tekland 2018S) and maintained at a room
temperature of 72.0 ⫾ 0.3 °F, room humidity of 40% ⫾ 2%, and
a 12-h light/12-h dark cycle, with the dark cycle starting at 18:00
h. For experiments that required fasting, the mice were transferred to clean cages containing floor grids, and food was
removed for the indicated time. All studies were conducted on
10 –14-week-old male mice and were approved by the Institutional Animal Care and Use Committees of West Virginia
University.
CoA analysis, immunoblotting, and RT-PCR
The concentration of total CoA (free CoA plus CoA thioesters) in kidney homogenates was determined after conversion
of the cofactor to the monobromobimane derivative, as previously described (25). For Western blotting analysis, flash frozen
tissues were homogenized in ice-cold radioimmunoprecipitation assay buffer supplemented with protease inhibitors
(Biotool) and centrifuged at 10,000 ⫻ g for 10 min at 4 °C. Proteins were fractionated on 4 –12% bis-Tris polyacrylamide gels
and transferred onto PVDF membranes. The GAPDH antibody
was used at a 1:3000 dilution; the Nudt7 and Nudt19 antibodies
were used at a 1:10,000 dilution. Bound primary antibodies
were detected by chemiluminescence with horseradish peroxidase-conjugated goat anti-rabbit IgG at a 1:45,000 dilution.
RNA was isolated from flash frozen tissue as previously
described (54). Following the removal of genomic DNA with
Turbo DNase-free kit (Thermo Fisher Scientific), Nudt19
mRNA levels were quantified in triplicate by RT-PCR using the
Quantitect SYBR Green RT-PCR kit (Qiagen), and the primers
were previously reported (54). The relative abundance of the
Nudt19 mRNA was calculated using the CT method, and the
amount (2⫺⌬CT) was reported relative to the mRNA of ␤-glucuronidase (GusB) (25).

Differential regulation of Nudt19 and Nudt7
Plasmid construction and mutagenesis
Wildtype mouse Nudt7 and Nudt19 were expressed as Nterminal hexahistine-tagged proteins from plasmids pKM204
(25) and pKM249, respectively. Plasmid pKM249 was a kind gift
from Dr. Suzanne Jackowski (St. Jude Children’s Research Hospital). The above plasmids were mutagenized with the Q5威 sitedirected mutagenesis kit to generate single-point Nudt7 and
Nudt19 mutants and a Nudt19 deletion mutant lacking amino
acids 58 –103. Insertion of the correct mutations was confirmed by sequencing analysis by the Genomics Core Facility at
West Virginia University. Sequences encoding Nudt7 and
Nudt19 chimeras were custom synthesized (Thermo Fisher
Scientific) to contain NdeI and NotI restriction sites at the 5⬘
and 3⬘ ends, respectively, codon-optimized for expression in
Escherichia coli and subcloned into pET-28a(⫹) (Millipore).
For the expression and localization of mouse Nudt19 in HEK
293 cells, custom pcDNA3.1(⫹)-derived constructs (GenScript) were assembled to express Nudt19 proteins, codon-optimized for expression in human cells, with N- or C-terminal
GFP tags.
Protein purification, analytical gel filtration chromatography,
and ITC
All Nudt7 and Nudt19 proteins with N-terminal hexahistidine tags were expressed in BL21 CodonPlus (DE3)-RIPL (Agilent Technologies) cells, following induction with 1 mM isopropyl ␤-D-1-thiogalactopyranoside and growth for 18 –20 h at
18 –25 °C. For enzymatic assay, the enzymes were purified as
previously described (25). Fractions containing ⬃90% pure
enzymes were combined and dialyzed overnight at 4 °C in
buffer containing 20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 1 mM
EDTA, and 1 mM dithiothreitol. Glycerol was added to a final
concentration of 50%, and proteins were stored at ⫺20 °C. Protein samples analyzed by analytical gel filtration chromatography were loaded (50 l) onto a Superdex 75 10/300 GL column
and eluted at 0.3 ml/min with 50 mM Tris-HCl, 150 mM NaCl,
pH 8.0. Protein elution was monitored by measuring the absorbance at 280 nm. For ITC studies, the purification procedure
included three chromatographic steps to increase the purity of
the proteins to ⬎98%, and the hexahistidine tag was removed.
Briefly, cell pellets were lysed in 50 mM Na2HPO4/NaH2PO4,
pH 8.0, 300 mM NaCl, 10 mM imidazole and centrifuged at
13,000 rpm for 45 min at 4 °C. The clarified supernatant was
allowed to bind to the nickel-nitrilotriacetic acid resin for 2 h
with stirring, before the suspension was transferred into a
column. The resin-bound proteins were washed with 50 mM
Na2HPO4/NaH2PO4, pH 8.0, 300 mM NaCl, 20 mM imidazole, followed by elution with wash buffer containing 50 –100
mM of imidazole. Protein-containing fractions were combined, dialyzed in buffer A (50 mM Na2HPO4/NaH2PO4, pH
8.0, 200 mM NaCl), and incubated with 0.04 unit/ml thrombin (Sigma–Aldrich) overnight at room temperature to
remove the hexahistine tag. The salt concentration of the
protein samples was then lowered with an additional dialysis
step in buffer B (50 mM Na2HPO4/NaH2PO4, 50 mM NaCl),
before applying the proteins onto a Resource15Q anion
exchange column equilibrated in buffer B. Proteins were

eluted with a 0 –100% gradient of buffer C (50 mM Na2HPO4/
NaH2PO4, pH 8.0, 500 mM NaCl), and the fractions containing the proteins of interested were pooled, dialyzed in buffer
A, and concentrated to 5 ml. The concentrated protein samples were subsequently loaded onto a HiLoad 26/60 Superdex 75-pg size exclusion column equilibrated in buffer A,
eluted in the same buffer, concentrated, and stored at
⫺80 °C.
Binding affinity of wildtype Nudt7 and Nudt19 for CDCA
was measured by ITC at 25 °C using a VP-ITC instrument
(Microcal Inc., Northhampton, MA) and 1.4 ml of purified
Nudt7 and Nudt19 dialyzed in ITC buffer (30 mM PIPES, pH
7.5, 50 mM NaCl, 2 mM MgCl2) and diluted to 124 and 55.5 M,
respectively. Protein solutions were degassed for at least 20
min. CDCA stock solutions were prepared in the same ITC
buffer. After an initial 2-l injection of CDCA solution with a
240-s equilibration time, the compound was titrated in 30 injections of 10 l each, added at 300-s intervals. The duration of
each injection was 12 s, and the filter period was 2 s. The stirring
speed and Feedback Mode/gain option were set up to 300 rpm
and “High” respectively. The heat evolved at 25 °C after each
ligand injection was obtained by integration of the calorimetric
signal after subtracting the average heat of dilution. Binding
parameters were determined from titration binding curves
using the MicroCal Data Analysis software (Malvern, Westborough, MA).
Enzymatic assays
The CoA diphosphohydrolase activity of the recombinant
enzymes was assayed, in duplicate, as previously described (25),
with minor modifications. The standard assay contained 10 ng
of recombinant Nudt7 or 30 ng of Nudt19, 100 mM Tris-HCl,
pH 8.0, 0.1 mg/ml ␥-globulin, an optimized concentration of
MgCl2, which was 4 mM for Nudt7 or 10 mM for Nudt19, and
250 M of free CoA or acyl-CoA substrates, in a total volume of
40 l. The reactions were incubated at 37 °C for 10 min and
stopped by the addition of perchloric acid. Following neutralization with potassium carbonate, the reaction mixtures were
diluted 5-fold with water, and the UV-visible 3⬘,5⬘-ADP product was separated and quantified by HPLC coupled with UV
detection on a 4.6 ⫻ 150 mm, 3-m C-18 column (Acclaim 120)
kept at 35 °C. Elution was performed at 0.7 ml/min as follows:
0 –2.5 min, 100% buffer A (50 mM KH2PO4, pH 4.6); 2.5–9.0
min linear gradient to 50% B (100% acetonitrile); 9.0 –10.0
min isocratic at 50% B; 10.0 –15.0 min linear gradient from
50% B to 75% B; 15.0 –19.0 min isocratic at 75% B; 19.0 –32.0
min return to 100% A, and column equilibration. A standard
curve of 3⬘,5⬘-ADP (Sigma–Aldrich) subjected to the same
reaction conditions was used to quantify the amount of
product formed. For each mutant and chimeric enzyme, protein curves were generated to select concentrations within
the activity linear range. The length of the assay was also
extended to 2 h for mutants exhibiting marginal activity. The
kinetic parameters Km, Vmax, and kcat were determined using
free CoA as the substrate, with concentrations ranging from
31.25 M to 10 mM, and obtained from curves fitted to
a Michaelis–Menten equation using GraphPad Prism 6
(GraphPad Software).
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To monitor the production of 3⬘,5⬘-ADP in kidney extracts,
flash-frozen tissue (⬃50 mg) was homogenized in 750 l of 20
mM Tris-HCl, pH 8.0. The homogenate was incubated on ice for
10 min and centrifuged at 20,000 ⫻ g for 10 min. The supernatant was loaded on to a PD10 column equilibrated in 20 mM
Tris-HCl, pH 8.0, to remove the small molecules. The eluted
proteins (50 –200 g) were incubated with 250 M free CoA for
5 min at 37 °C. The reactions were then stopped and analyzed as
described above.
Immunofluorescence
HEK 293 cells were cultured at 37 °C and 5% CO2 in phenol
red-free Opti-MEM I medium supplemented with 4% FBS, 100
units/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml
amphotericin B. To localize Nudt19, the cells were seeded on
12-mm coverslips at low density and grown in the same
medium to ⬃80% confluence. Transfections were performed
with 1.25 g of plasmid DNA using Lipofectamine 2000, as per
the manufacturer’s instructions. Where indicated, the cells
were incubated with MitoTracker威 Orange CMTMRos at a
concentration of 25 nM for 30 min at 37 °C. The cells were fixed
with 4% paraformaldehyde and blocked in PBS containing 5%
FBS and 0.3% Triton X-100 for 1 h at room temperature. The
PMP70 antibody was used at a 1:1000 dilution in 1% BSA, 0.3%
Triton X-100 for 1 h at room temperature. Following 10 washes
with PBS, the cells were incubated for 1 h at room temperature
with Alexa Flour 555 donkey anti-mouse IgG, used at a dilution of 1:1000 in 1% BSA, 0.3% Triton X-100. Slides were
mounted using Prolong Gold Antifade with DAPI (Thermo
Fisher). Imaging experiments were performed in the West
Virginia University Imaging Facilities using a Nikon A1R/N
SIM-E confocal microscope. Image analysis was conducted
using ImageJ.
Molecular modeling
Homology models with bound Mg2⫹ were built using the
software suite YASARA (43) (www.yasara.org).4 The models
showing the expected orientation of E16N, E19N, and E20N with
respect to the Mg2⫹ ion were selected and prepared for docking
studies with free CoA by adding hydrogens at pH 7.4 in the
modeling program MOE 2016 (www.chemcomp.com; Ref.
57).4 After an induced fit docking step, the top five poses were
evaluated for the correct relative orientation of the diphosphate
moiety of free CoA, the bound Mg2⫹, and Nudt19 Arg-34 or
NUDT7 Arg-60. Sequence alignments were obtained using
Clustal W (55) and combined with secondary structure elements using ESPript 3 (56). The Nudt19 model and the crystal
structures of human NUDT7 and the bacterial CoAse were
aligned using Phenix Ensembler (23).
Statistical analysis
Unless otherwise stated, all data are reported as the means
with ⫾ S.D. Statistical significance was calculated by unpaired
two-tailed Student’s t test using GraphPad Prism 6 (GraphPad
Software).
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